CC - Company ID 0001627223
Chemours Co (CC) reported revenue of $5.81B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $5.81B | +0.4% |
| FY 2024 | $5.78B | -4.9% |
| FY 2023 | $6.08B | -11.0% |
| FY 2022 | $6.83B | +7.7% |
| FY 2021 | $6.34B | +27.7% |
| FY 2020 | $4.97B | -10.1% |
| FY 2019 | $5.53B | -16.8% |
| FY 2018 | $6.64B | +7.4% |
| FY 2017 |
Chemours Co (CC) reported revenue of $5.81B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2013 and fiscal 2025, Chemours Co's revenue declined from $6.86B to $5.81B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $6.18B |
| +14.5% |
| FY 2016 | $5.40B | -5.5% |
| FY 2015 | $5.72B | -11.1% |
| FY 2014 | $6.43B | -6.2% |
| FY 2013 | $6.86B | - |